process, so member firms within the consortium become the assignees of the patents.

In summary, Dr. Mowery characterized his talk as “a brief laundry list of issues,” which could be useful as “a roadmap of sorts” to establish points of contrast and similarity. With such a roadmap, he suggested, one could think profitably about how “this unusual instrument of R&D collaboration” will likely evolve in response to ongoing changes in industry and market structures.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement